Browse Type 2 diabetes topic

Drug therapy subtopic

Articles 1-85 out of 85 article(s) Title Author Type Date Words GI Dynamics Receives European CE Mark Approval for the EndoBarrier[TM] Gastrointestinal Liner System for the Treatment of Type 2 Diabetes and Obesity. Dec 22, 2009 826 Takeda and Pfizer to Co-Promote Takeda's Actos[R] (Pioglitazone HCl) for the Treatment of Type 2 Diabetes in China. Dec 15, 2009 567 Popular diabetes drugs could elevate risk of heart failure and death. Dec 4, 2009 339 Pharmacology Watch: Insulin Regimens in Type 2 Diabetes. Dec 1, 2009 1315 United States : BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes. Oct 31, 2009 476 GI Dynamics' EndoBarrier[TM] Gastrointestinal Liner Demonstrates Safety and Efficacy in Pre-surgical Weight Loss. Oct 27, 2009 1057 ONGLYZA[TM] (saxagliptin) Receives Marketing Authorisation In Europe For The Treatment Of Type 2 Diabetes. Oct 5, 2009 1259 Germany : European Commission Approves Januvia [R] (sitagliptin) for Restricted First Line Use in Treatment of Type 2 Diabetes. Sep 8, 2009 359 Netherlands : SynCo Bio Partners to manufacture Versartis type 2 diabetes drug. Aug 17, 2009 230 Israeli Breakthru Research: No More Insulin Shots for Diabetics. Brief article Aug 11, 2009 82 United States : F.D.A. Approves Onglyza, a New Drug for Type 2 Diabetes. Aug 1, 2009 287 U.S. Food and Drug Administration Approves ONGLYZA[TM] (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults. Jul 31, 2009 2206 New Drug Application for Exenatide Once Weekly Accepted for Review by FDA. Jul 7, 2009 1369 ONGLYZA[TM] (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes. Jun 25, 2009 1235 VIAject[R] Presentations at ADA Meeting Highlight Drug's Mechanism of Absorption and Microvascular Effects. Clinical report Jun 8, 2009 897 VeroScience Presents Data on Newly FDA Approved Drug Cycloset at American Diabetes Association Annual Scientific Sessions. Jun 6, 2009 1160 In Investigational Studies, New Uses of JANUVIA[TM] (sitagliptin) in Combination with Other Diabetes Medicines Resulted in Significant Blood Sugar-Lowering Efficacy for Patients with Type 2 Diabetes. Jun 6, 2009 25139 New drug to treat diabetes via the brain. May 8, 2009 460 VeroScience Announces FDA Approval of Cycloset for Treatment of Type 2 Diabetes. May 6, 2009 977 U.S. Food and Drug Administration Extends Review Timeline for ONGLYZA[TM] (saxagliptin) New Drug Application. Chronology Apr 23, 2009 677 Diabetics are given drugs 'too soon', instead of promoting 'lifestyle change'. Mar 7, 2009 425 Popular class of diabetes drugs doubles fractures risk in women, finds Indian-origin boffin. Dec 10, 2008 460 Competitive Intelligence Report on Sodium-Dependent Glucose (Co)Transporter (SGLT) Inhibitors Provides a Competitor Analysis for Treatment of Type 2 Diabetes. Nov 10, 2008 276 An Essential Competitor Analysis Report on the Development Pipeline of Novel Dipeptidyl Peptidase IV (DPP-IV) Inhibitors for Type 2 Diabetes. Nov 7, 2008 289 Metabasis Therapeutics Announces Initiation of a Clinical Trial for MB07803, Its Novel Product Candidate for the Treatment of Type 2 Diabetes. Sep 23, 2008 935 CV safety studies needed for new diabetes drugs. Mechcatie, Elizabeth Aug 1, 2008 785 Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes. Jul 23, 2008 631 FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes. Jun 24, 2008 2176 OSI Pharmaceuticals Presents Diabetes/Obesity Preclinical Compounds, PSN821 and PSN602, at Annual Meeting of the American Diabetes Association. Jun 10, 2008 933 Ipsen: Roche Moves Investigational Diabetes Drug, Taspoglutide, into Phase III Clinical Trials. Jun 10, 2008 1747 Sirtris Pharmaceuticals Presents at the American Diabetes Association's 68th Annual Scientific Sessions June 8. Jun 4, 2008 630 Elixir Pharmaceuticals Establishes National Diabetes Advisory Board. Apr 9, 2008 1794 Metabasis Therapeutics Presents the Discovery of Its Second-Generation FBPase Inhibitor, MB07803, at the 235th American Chemical Society National Meeting. Apr 7, 2008 1071 Pharmacology Watch: Erythropoietin and Cancer Death Rates. Apr 1, 2008 1436 Elixir Announces Completion of Enrollment in Pivotal Phase III Clinical Trial for New Diabetes Drug. Clinical report Mar 25, 2008 1020 Metabasis Therapeutics Completes Enrollment of Its Proof-of-Concept Clinical Trial for MB07803, Its Product Candidate for the Treatment of Type 2 Diabetes. Feb 28, 2008 1077 European health authorities support changes to Novartis prescribing information paving for type 2 diabetes treatment use. Jan 1, 2008 234 Sirtris Pharmaceuticals' SIRT1 Activator Controls Glucose as well as a DPP-4 inhibitor in a Pre-Clinical Model of Type 2 Diabetes. Dec 13, 2007 529 Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus / Tip 2 diyabetes mellituslu hipertansif hastalarda nebivolol ve metoprolol tedavilerinin serum asimetrik dimetilarginin duzeyleri uzerine etkisi. Oguz, Aytekin; Uzunlulu, Mehmet; Yorulmaz, Elif; Yalcin, Yavuz; Hekim, Nezih; Fici, Francesco Clinical report Dec 1, 2007 4903 FDA Accepts Akesis Pharmaceuticals' AKP-020 IND Application for a Phase IIa Study in the Treatment of Type 2 Diabetes. Nov 12, 2007 560 FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin). Oct 17, 2007 13103 Akesis Pharmaceuticals Files IND for Phase IIa Trial of AKP-020 to Treat Type 2 Diabetes. Oct 8, 2007 658 Sirtris Pharmaceuticals to Present at the Targeting Obesity Conference: Solutions and Therapeutics on September 27, 2007. Conference news Sep 25, 2007 374 Breakthrough claim for type-2 diabetes drug. Jun 28, 2007 378 Elixir Pharmaceuticals Announces Clinical Data at American Diabetes Association Conference Highlighting Ability of Glufast(R) to Maintain Glycemic Control in Patients with Type 2 Diabetes. Jun 25, 2007 1281 Diabetes warning feeds debate over drug safety; Study links Avandia to heart trouble; Drug firm says analysis flawed. Clinical report May 22, 2007 1360 FDA Approves JANUMET(TM) for Type 2 Diabetes, Offering Powerful Glucose Control of a DPP-4 Inhibitor and Metformin in a Single Tablet. Apr 2, 2007 13219 Hollis-Eden Pharmaceuticals Announces Filing of IND for Phase I Clinical Trial with Next-Generation Drug Candidate HE3286 in Metabolic Disorders. Mar 29, 2007 1717 JANUVIA(TM) Approved in the European Union for the Treatment of Type 2 Diabetes. Mar 26, 2007 8996 Phenomix Completes Phase 2a Clinical Trial - Diabetes Drug is Efficacious and Well Tolerated. Mar 5, 2007 465 Early use of insulin in the management of type 2 diabetes--the time is now. King, Dana E. Disease/Disorder overview Feb 1, 2007 874 Why and how to use insulin therapy earlier in the management of type 2 diabetes. Meneghini, Luigi Feb 1, 2007 9497 JANUVIA(TM), First in New Class of Oral Treatments Known as DPP-4 Inhibitors, Recommended for Approval for the Treatment of Type 2 Diabetes in the European Union. Jan 25, 2007 8996 JANUVIA(R), First in New Class of Oral Treatments Known as DPP-4 Inhibitors, Recommended for Approval for the Treatment of Type 2 Diabetes in the European Union. Jan 25, 2007 1036 Joslin Diabetes Center Launches National Clinical Trial To Explore If Anti-Inflammatory Drug Can Improve Glucose Control in Type 2 Diabetes. Jan 16, 2007 830 PhytoMedical to Fast Track Development of New Class of Drug for Type-2 Diabetes. Dec 4, 2006 1522 New type 2 diabetes pill arrives -- at $4.86 apiece; Merck's Januvia; Fewer side effects than older drugs -- but much costlier. Oct 18, 2006 560 Drug offers hope of a diabetes breakthrough. Sep 16, 2006 207 Drug may slow development of diabetes. Sep 16, 2006 555 New Phase III Data Showed Significant Glucose-Lowering Efficacy of JANUVIA(TM), an Investigational Medicine for Type 2 Diabetes, When Taken Simultaneously with Metformin. Sep 14, 2006 1655 New Once-Daily Oral Diabetes Treatment Glumetza(TM) Now Available. Sep 6, 2006 1574 Understand the Key Factors That Will Contribute To the Success of the Next Generation of Anti-Diabetes Drugs. Aug 30, 2006 403 Depomed and King Pharmaceuticals Prepare for Launch of Glumetza(TM) as Timely, New ADA Guidelines Are Issued; Consensus Statement Recommends That Metformin Be Added to Lifestyle Changes as Initial Treatment for Type 2 Diabetes. Aug 23, 2006 1334 JANUVIA(TM) (Sitagliptin Phosphate) Receives Approval In Mexico; Approval of JANUVIA in Mexico Marks the First DPP-4 Inhibitor, a New Class of Oral Type 2 Diabetes Medicines, To Be Approved in the World. Aug 8, 2006 401 Merck Announces FDA Acceptance of New Drug Application for MK-0431A, an Investigational Fixed Dose Combination of JANUVIA(TM) and Metformin for Type 2 Diabetes. Jul 31, 2006 523 In New Data at One Year, JANUVIA(TM), an Investigational Medicine for Type 2 Diabetes, Demonstrated Substantial Glucose-Lowering Effect, with Significant Differences Compared to Glipizide (a Sulfonylurea) in Weight Change and Hypoglycemia. Jun 13, 2006 1653 PhytoMedical accelerates development for type 2 diabetes compound. Brief article Mar 1, 2006 140 Amgen and Biovitrum Expand Existing License Agreement for Innovative Treatment of Type 2 Diabetes and Other Metabolic Disorders. Feb 13, 2006 1289 Amgen and Biovitrum Expand Existing License Agreement for Innovative Treatment of Type 2 Diabetes and Other Metabolic Disorders. Feb 13, 2006 1284 Sanguine Evaluates a New Science Approach to Use PHER-O2 in Conjunction with Type 2 Diabetes Therapies. Feb 7, 2006 354 Type II diabetics. Brief article Feb 1, 2006 92 Kids respond to oral medication. Brief article Feb 1, 2006 272 We can learn to heal ourselves; Pharmaceutical company joins fight against diabetes and aims for a better life for all. Nov 29, 2005 469 Dipeptidyl peptidase-4 inhibition in type 2 diabetes mellitus. Pratley, Richard E.; Salsali Afshin Feb 1, 2005 1649 Better blood sugar control may improve memory. Tucker, Miriam E. Dec 1, 2004 421 Pycnogenol[R] found to lower glucose levels in type 2 diabetics. Brief Article May 1, 2004 92 Treatment for diabetes dependent on the cause. Dec 22, 2003 143 Insulin plus metformin vs triple oral therapy in type 2 diabetes. Kuritzky, Louis Brief Article Nov 1, 2003 278 Diabetes drug results drive Amylin stock. Webb, Marion Aug 11, 2003 410 Diabetes drug prescribed when contraindicated. Mar 22, 2003 488 Adenosine Therapeutics licenses patented method for improving insulin sensitivity. Brief Article May 1, 2001 592 MEDICAL PROGRESS. Mar 1, 2001 292 UPDATE: Thiazolidinedione Group. Pamphlet May 24, 2000 463 Bitter Pill. WILLMAN, DAVID Sep 1, 1999 4045 Hormone triggers cells to turn to fat. Travis, John Dec 9, 1995 574